entertainment -WSS

entertainment

author：knowledge 2025-09-27 16:50:27 - browse：4275

Jennifer Doudna Feng Zhang CRISPR — CRISPR pioneers Jennifer Doudna and Feng Zhang Illustration: STAT; Photos: AP, Getty

The revolution started in silence.

Jennifer Doudna and Emmanuelle Charpentier, now Nobelists, published their first paper announcing a new enzyme for editing DNA in Science in June 2012. It was called CRISPR-Cas9. It wasn’t until January 2013 that the first paper showing the enzyme would work in cells, from Feng Zhang, was published, also in Science. A similar paper from George Church came out at the same time.

No major media outlet covered the papers. The first story on CRISPR was published that March. But within the ivory tower of academia, it was clear something big was building, as requests for the technology poured in from other researchers and Zhang set up an assembly line in his laboratory to distribute it, with students carrying carefully packed samples to a FedEx office down the street.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Scientists inch closer to single

WSS

Lawsuit alleges UnitedHealth Group unit illegally denied claims

‘Oppenheimer’ and the risks of AI in health care

Physician groups backed by private equity giant lobby on mergers

FDA poised to publish guidelines for clinical trial diversity

Listen: More tumult at BIO & coercive care for sickle cell patients

Hyundai and Kia recall nearly 92,000 vehicles and tell owners to park them outside due to fire risk

knowledge

entertainment

knowledge

Medicare proposal to cover medical devices draws a mixed reaction

Micronoma's microbiome cancer diagnostic approach under fire

The cancer drug shortage isn’t new — and neither are the solutions

What the airline industry can learn from medicine

Jerome Adams on the need for new antivirals for Covid

H5N1 bird flu outbreak: Second human case reported, in Michigan

Trump demands the U.S. pay no more for drugs than other countries … again

Study finds gene variants tied to breast cancer risk in Black women

Drug repurposing or repositioning? The language matters

Sage hopes for a blockbuster in antidepressant now before FDA

explore

Amazon expands telehealth clinic nationwide

Cue Health, Covid

Bird flu surveillance in wastewater gets boost from consortium

Addressing health care workers' trauma can help fight burnout

Fentanyl is making it harder to start addiction treatment

Listen: Biogen's situation, Wegovy's risks, & biotech insider trading

explore

knowledge

knowledge

hotspot